Histidine and tyrosine residues are targets for SIRT6 ADP-ribosylation activity
Open Biology · 04.03.2026 · 16 (3)
DOI: 10.1098/rsob.250181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Biology, online erschienen am 04.03.2026. Verfasst von Johannes Gregor Matthias Rack und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Council Centre for Medical Mycology at the University of Exeter, Department of Biosciences, Faculty of Health and Life Sciences, Exe…. Hauptthemen laut MEDLINE: Sirtuins, ADP-Ribosylation, Tyrosine, Histidine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Exeter Biomedical Research Centre, Ministero dell'Università e della Ricerca, Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
SIRT6, a highly conserved member of the sirtuin family, plays a critical role in diverse cellular processes, including gene regulation, DNA damage response and maintaining nuclear lamina integrity. These functions are essential in contexts such as differentiation, metabolic regulation, cancer development and ageing. Given the multifaceted influence of SIRT6 on cellular activities, there is an increasing interest in elucidating the regulatory mechanisms governing its enzymatic functions. SIRT6 exhibits two NAD+-dependent activities: deacetylation and ADP-ribosylation, with current research predominantly focusing on the former. However, the latter—its (ADP-ribosyl)transferase activity—remains underexplored, particularly concerning the specific amino acid targets it modifies and the (ADP-ribosyl)hydrolases that can reverse these modifications. In this study, we have utilized biochemical assays and proteomic techniques to investigate these aspects, revealing that SIRT6 transfers ADP-ribosyl moieties onto histidine and tyrosine residues. In addition, we reveal that the (ADP-ribosyl)hydrolase ARH3 has significant activity in erasing SIRT6-derived ADP-ribosylation in cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Research Council Centre for Medical Mycology at the University of Exeter, Department of Biosciences, Faculty of Health and Life Sciences, Exeter, Devon,EX4 4QD, UK.
- Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
- Department of Translational Medical Sciences, University of Naples Federico II, Naples, Campania, Italy.
- Institute of Genetics, HUN-REN Biological Research Centre Szeged, Szeged, Csongrád, Hungary.
- Doctoral School of Multidisciplinary Medical Sciences, University of Szeged, Szeged, Csongrád, Hungary.
- Institute for Genetics, University of Cologne, Cologne, North Rhine-Westphalia, Germany.
ORCID-Profile: Ivan Ahel, Luca Palazzo
Förderung
- NIHR Exeter Biomedical Research Centre
- Ministero dell'Università e della Ricerca
- Biotechnology and Biological Sciences Research Council
- Cancer Research UK
- Ovarian Cancer Research Alliance
- Medical Research Council Centre for Medical Mycology
- Deutsche Forschungsgemeinschaft
- European Molecular Biology Organization
Zitieren
APA
Rack, J. G. M., Prokhorova, E., Lauro, R., Kopasz, A. G., Baretić, D., Raggiaschi, R., Mutabdzija, J., Filippov, D. V., Timinszky, G., Leidecker, O., Ahel, I., & Palazzo, L. (2026). Histidine and tyrosine residues are targets for SIRT6 ADP-ribosylation activity. Open Biology, 16(3). https://doi.org/10.1098/rsob.250181
Vancouver
Rack JGM, Prokhorova E, Lauro R, Kopasz AG, Baretić D, Raggiaschi R, et al. Histidine and tyrosine residues are targets for SIRT6 ADP-ribosylation activity. Open Biology. 2026;16(3). doi:10.1098/rsob.250181
BibTeX
@article{Rack2026,
author = {Rack, Johannes Gregor Matthias and Prokhorova, Evgeniia and Lauro, Raffaella and Kopasz, Anna Georgina and Baretić, Domagoj and Raggiaschi, Roberto and Mutabdzija, Jovana and Filippov, Dmitri V and Timinszky, Gyula and Leidecker, Orsolya and Ahel, Ivan and Palazzo, Luca},
title = {Histidine and tyrosine residues are targets for SIRT6 ADP-ribosylation activity},
journal = {Open Biology},
year = {2026},
volume = {16},
number = {3},
doi = {10.1098/rsob.250181}
}
EUVIMED